{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T23:02:47Z","timestamp":1782255767930,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["2 U01 DA01363"],"award-info":[{"award-number":["2 U01 DA01363"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10461-020-03090-y","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T07:03:35Z","timestamp":1605510215000},"page":"1247-1256","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["HIV-Risk Behavior Among Adults with Opioid Use Disorder During 12 Months Following Pre-trial Detention: Results from a Randomized Trial of Methadone Treatment"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6984-5085","authenticated-orcid":false,"given":"M. M.","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. M.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. E.","family":"O\u2019Grady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. G.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. P.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"issue":"48","key":"3090_CR1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.15585\/mmwr.mm6848e1","volume":"68","author":"NS Harris","year":"2019","unstructured":"Harris NS, Johnson AS, Huang YA, Kern D, Fulton P, Smith DK, et al. Vital signs: status of human immunodeficiency virus testing, viral suppression, and HIV preexposure prophylaxis\u2014United States, 2013\u20132018. MMWR Morb Mortal Wkly Rep. 2019;68(48):1117\u201323.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3090_CR2","unstructured":"Maruschak L, Bronson J. HIV in Prisons, 2015\u2014statistical tables. In: U.S. Department of Justice, ed. Washington: Bureau of Justice Statistics. 2017."},{"issue":"50\u201351","key":"3090_CR3","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","volume":"64","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths-United States, 2000\u20132014. MMWR Morb Mortal Wkly Rep. 2016;64(50\u201351):1378\u201382.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"3090_CR4","first-page":"CD002209","volume":"3","author":"RP Mattick","year":"2009","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;3:CD002209.","journal-title":"Cochrane Database Syst Rev"},{"key":"3090_CR5","first-page":"CD002207","volume":"2","author":"RP Mattick","year":"2014","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev. 2014;2:CD002207.","journal-title":"Cochrane Database Syst Rev"},{"key":"3090_CR6","first-page":"CD011117","volume":"5","author":"S Nielsen","year":"2016","unstructured":"Nielsen S, Larance B, Degenhardt L, Gowing L, Kehler C, Lintzeris N. Opioid agonist treatment for pharmaceutical opioid dependent people. Cochrane Database Syst Rev. 2016;5:CD011117.","journal-title":"Cochrane Database Syst Rev"},{"key":"3090_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.drugalcdep.2014.03.006","volume":"139","author":"EJ Edelman","year":"2014","unstructured":"Edelman EJ, Chantarat T, Caffrey S, Chaudhry A, O\u2019Connor PG, Weiss L, et al. The impact of buprenorphine\/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients. Drug Alcohol Depend. 2014;139:79\u201385.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"3090_CR8","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s11606-006-0258-x","volume":"21","author":"LR Gowing","year":"2006","unstructured":"Gowing LR, Farrell M, Bornemann R, Sullivan LE, Ali RL. Brief report: methadone treatment of injecting opioid users for prevention of HIV infection. J Gen Intern Med. 2006;21(2):193\u20135.","journal-title":"J Gen Intern Med"},{"issue":"2","key":"3090_CR9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jsat.2006.04.005","volume":"31","author":"DC Lott","year":"2006","unstructured":"Lott DC, Strain EC, Brooner RK, Bigelow GE, Johnson RE. HIV risk behaviors during pharmacologic treatment for opioid dependence: a comparison of levomethadyl acetate [corrected] buprenorphine, and methadone. J Subst Abuse Treat. 2006;31(2):187\u201394.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"3090_CR10","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.drugpo.2009.10.004","volume":"21","author":"RD Bruce","year":"2010","unstructured":"Bruce RD. Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings. Int J Drug Policy. 2010;21(2):122\u20134.","journal-title":"Int J Drug Policy"},{"key":"3090_CR11","first-page":"e1229","volume":"2","author":"P Karki","year":"2016","unstructured":"Karki P, Shrestha R, Huedo-Medina TB, Copenhaver M. The impact of methadone maintenance treatment on HIV risk behaviors among high-risk injection drug users: a systematic review. Evid Based Med Public Health. 2016;2:e1229.","journal-title":"Evid Based Med Public Health"},{"issue":"1","key":"3090_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1001\/archinte.1990.00390130099014","volume":"150","author":"DM Novick","year":"1990","unstructured":"Novick DM, Joseph H, Croxson TS, Salsitz EA, Wang G, Richman BL, et al. Absence of antibody to human immunodeficiency virus in long-term, socially rehabilitated methadone maintenance patients. Arch Intern Med. 1990;150(1):97\u20139.","journal-title":"Arch Intern Med"},{"issue":"9","key":"3090_CR13","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.2105\/AJPH.81.9.1185","volume":"81","author":"SR Yancovitz","year":"1991","unstructured":"Yancovitz SR, Des Jarlais DC, Peyser NP, Drew E, Friedmann P, Trigg HL, et al. A randomized trial of an interim methadone maintenance clinic. Am J Public Health. 1991;81(9):1185\u201391.","journal-title":"Am J Public Health"},{"issue":"1","key":"3090_CR14","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1001\/archpsyc.63.1.102","volume":"63","author":"RP Schwartz","year":"2006","unstructured":"Schwartz RP, Highfield DA, Jaffe JH, Brady JV, Butler CB, Rouse CO, et al. A randomized controlled trial of interim methadone maintenance. Arch Gen Psychiatry. 2006;63(1):102\u20139.","journal-title":"Arch Gen Psychiatry"},{"key":"3090_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181f9c0f7","author":"CG Beckwith","year":"2010","unstructured":"Beckwith CG, Zaller ND, Fu JJ, Montague BT, Rich JD. Opportunities to diagnose, treat, and prevent HIV in the criminal justice system. J Acquir Immune Defic Syndr (1999). 2010. https:\/\/doi.org\/10.1097\/QAI.0b013e3181f9c0f7.","journal-title":"J Acquir Immune Defic Syndr (1999)"},{"issue":"1","key":"3090_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1177\/0011128791037001007","volume":"37","author":"S Magura","year":"1991","unstructured":"Magura S, Rosenblum A, Joseph H. AIDS-risk among intravenous drug-using offenders. Crime Delinq. 1991;37(1):86\u2013100.","journal-title":"Crime Delinq"},{"issue":"11","key":"3090_CR17","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.2105\/AJPH.2014.302152","volume":"104","author":"K Underhill","year":"2014","unstructured":"Underhill K, Dumont D, Operario D. HIV prevention for adults with criminal justice involvement: a systematic review of HIV risk-reduction interventions in incarceration and community settings. Am J Public Health. 2014;104(11):e27\u201353.","journal-title":"Am J Public Health"},{"issue":"8","key":"3090_CR18","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1007\/s10461-011-9990-2","volume":"17","author":"LM Adams","year":"2013","unstructured":"Adams LM, Kendall S, Smith A, Quigley E, Stuewig JB, Tangney JP. HIV risk behaviors of male and female jail inmates prior to incarceration and one year post-release. AIDS Behav. 2013;17(8):2685\u201394.","journal-title":"AIDS Behav"},{"issue":"8","key":"3090_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1258\/095646203767869110","volume":"14","author":"RJ MacGowan","year":"2003","unstructured":"MacGowan RJ, Margolis A, Gaiter J, Morrow K, Zack B, Askew J, et al. Predictors of risky sex of young men after release from prison. Int J STD AIDS. 2003;14(8):519\u201323. https:\/\/doi.org\/10.1258\/095646203767869110.","journal-title":"Int J STD AIDS"},{"key":"3090_CR20","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1471-2458-9-156","volume":"9","author":"MJ Milloy","year":"2009","unstructured":"Milloy MJ, Buxton J, Wood E, Li K, Montaner JS, Kerr T. Elevated HIV risk behaviour among recently incarcerated injection drug users in a Canadian setting: a longitudinal analysis. BMC Public Health. 2009;9:156.","journal-title":"BMC Public Health"},{"key":"3090_CR21","unstructured":"Zhen Zeng. Jail Inmates in 2016 U.S. Department of Justice Office of Justice Programs Bureau of Justice Statistics. NCJ 251210.12. 2018."},{"key":"3090_CR22","unstructured":"Carson EA. Bureau of Justice Statistics | Office of Justice Programs. U.S. Department of Justice. Prisoners in 2016. Summary| NCJ 251149 2018."},{"issue":"1","key":"3090_CR23","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13011-017-0107-4","volume":"12","author":"R Chandler","year":"2017","unstructured":"Chandler R, Gordon MS, Kruszka B, Strand LN, Altice FL, Beckwith CG, et al. Cohort profile: seek, test, treat and retain United States criminal justice cohort. Subst Abuse Treat Prev Policy. 2017;12(1):24.","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"3090_CR24","first-page":"27","volume":"7","author":"A Sharma","year":"2016","unstructured":"Sharma A, O\u2019Grady KE, Kelly SM, Gryczynski J, Mitchell SG, Schwartz RP. Pharmacotherapy for opioid dependence in jails and prisons: research review update and future directions. Subst Abuse Rehabil. 2016;7:27\u201340.","journal-title":"Subst Abuse Rehabil"},{"key":"3090_CR25","unstructured":"Metzger D, Woody GE, Navaline H, McLellan AT, Meyers K, Boney T, et al. The risk assessment battery (RAB): Validity and reliability. In: Sixth Annual Meeting of National Cooperative Vaccine Development Group for AIDS. University of Pennsylvania, Center for Studies on Addition, Philadelphia: PA. 1993."},{"key":"3090_CR26","unstructured":"UPENN. Risk Assessment Battery. HIV\/AIDS Research Prevention Division. Perelman School of Medicine. University of Pennsylvania. Available at: https:\/\/www.med.upenn.edu\/hiv\/rab_download.html. Accessed 20 Apr 2020."},{"issue":"5","key":"3090_CR27","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/j.1521-0391.2012.00250.x","volume":"21","author":"ME Wilson","year":"2012","unstructured":"Wilson ME, Kinlock TW, Gordon MS, O\u2019Grady KE, Schwartz RP. Postprison release HIV-risk behaviors in a randomized trial of methadone treatment for prisoners. Am J Addict. 2012;21(5):476\u201387.","journal-title":"Am J Addict"},{"issue":"1\u20133","key":"3090_CR28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.drugalcdep.2008.08.006","volume":"99","author":"S Magura","year":"2009","unstructured":"Magura S, Lee JD, Hershberger J, Joseph H, Marsch L, Shropshire C, et al. Buprenorphine and methadone maintenance in jail and post-release: a randomized clinical trial. Drug Alcohol Depend. 2009;99(1\u20133):222\u201330.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"3090_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/08897077.2011.609446","volume":"33","author":"M McKenzie","year":"2012","unstructured":"McKenzie M, Zaller N, Dickman SL, Green TC, Parihk A, Friedmann PD, et al. A randomized trial of methadone initiation prior to release from incarceration. Subst Abuse. 2012;33(1):19\u201329.","journal-title":"Subst Abuse"},{"issue":"Suppl 2","key":"3090_CR30","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1097\/QAI.0000000000000624","volume":"69","author":"SA Strathdee","year":"2015","unstructured":"Strathdee SA, West BS, Reed E, Moazen B, Azim T, Dolan K. Substance use and HIV among female sex workers and female prisoners: risk environments and implications for prevention, treatment, and policies. J Acquir Immune Defic Syndr. 2015;69(Suppl 2):S110\u20137.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"10","key":"3090_CR31","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1007\/s10461-017-1722-9","volume":"21","author":"KB Loeliger","year":"2017","unstructured":"Loeliger KB, Biggs ML, Young R, Seal DW, Beckwith CG, Kuo I, et al. Gender differences in HIV risk behaviors among persons involved in the U.S. criminal justice system and living with HIV or at risk for HIV: a \u201cSeek, Test, Treat, and Retain\u201d Harmonization Consortium. AIDS Behav. 2017;21(10):2945\u201357.","journal-title":"AIDS Behav"},{"key":"3090_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-019-02726-y","author":"MM Mitchell","year":"2019","unstructured":"Mitchell MM, Gryczynski J, Mitchell SG, Kelly SM, O\u2019Grady KE, Monico LB, et al. A latent class analysis of HIV risk factors among men and women with opioid use disorder in pre-trial detention. AIDS Behav. 2019. https:\/\/doi.org\/10.1007\/s10461-019-02726-y.","journal-title":"AIDS Behav"},{"key":"3090_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cct.2016.08.004","volume":"50","author":"JD Lee","year":"2016","unstructured":"Lee JD, Nunes EV, Bailey GL, Brigham GS, Cohen AJ, Fishman M, et al. NIDA Clinical Trials Network CTN-0051, extended-release naltrexone vs. buprenorphine for opioid treatment (X: BOT): study design and rationale. Contemp Clin Trials. 2016;50:253\u201364.","journal-title":"Contemp Clin Trials"},{"issue":"8","key":"3090_CR34","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.2105\/AJPH.83.8.1144","volume":"83","author":"RE Booth","year":"1993","unstructured":"Booth RE, Watters JK, Chitwood DD. HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack. Am J Public Health. 1993;83(8):1144\u20138.","journal-title":"Am J Public Health"},{"issue":"1","key":"3090_CR35","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0376-8716(94)01058-S","volume":"37","author":"DA Bux","year":"1995","unstructured":"Bux DA, Lamb R, Iguchi MY. Cocaine use and HIV risk behavior in methadone maintenance patients. Drug Alcohol Depend. 1995;37(1):29\u201335.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"3090_CR36","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/ADM.0000000000000583","volume":"14","author":"NP Morris","year":"2020","unstructured":"Morris NP, Bentzley BS. Supporting the use of medications for addiction treatment in US drug courts: opportunities for health professionals. J Addict Med. 2020;14(4):277\u20139.","journal-title":"J Addict Med"},{"issue":"2","key":"3090_CR37","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0306624X18789832","volume":"63","author":"M Baughman","year":"2019","unstructured":"Baughman M, Tossone K, Singer MI, Flannery DJ. Evaluation of treatment and other factors that lead to drug court success, substance use reduction, and mental health symptomatology reduction over time. Int J Offender Ther Comp Criminol. 2019;63(2):257\u201375.","journal-title":"Int J Offender Ther Comp Criminol"},{"issue":"2","key":"3090_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/ADM.0b013e318284a0c1","volume":"7","author":"SM Kelly","year":"2013","unstructured":"Kelly SM, O\u2019Grady KE, Jaffe JH, Gandhi D, Schwartz RP. Improvements in outcomes in methadone patients on probation\/parole regardless of counseling early in treatment. J Addict Med. 2013;7(2):133.","journal-title":"J Addict Med"},{"issue":"1","key":"3090_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/0022042613491106","volume":"44","author":"SG Mitchell","year":"2014","unstructured":"Mitchell SG, Gryczynski J, Kelly SM, O\u2019Grady KE, Jaffe JH, Olsen YK, et al. Treatment outcomes of African American buprenorphine patients by parole and probation status. J Drug Issues. 2014;44(1):69\u201382.","journal-title":"J Drug Issues"},{"issue":"3","key":"3090_CR40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1108\/IJPH-03-2017-0016","volume":"14","author":"L Azbel","year":"2018","unstructured":"Azbel L, Wegman MP, Polonsky M, Bachireddy C, Meyer J, Shumskaya N, et al. Drug injection within prison in Kyrgyzstan: elevated HIV risk and implications for scaling up opioid agonist treatments. Int J Prison Health. 2018;14(3):175\u201387.","journal-title":"Int J Prison Health"},{"key":"3090_CR41","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.drugalcdep.2015.01.018","volume":"149","author":"GJ Culbert","year":"2015","unstructured":"Culbert GJ, Waluyo A, Iriyanti M, Muchransyah AP, Kamarulzaman A, Altice FL. Within-prison drug injection among HIV-infected male prisoners in Indonesia: a highly constrained choice. Drug Alcohol Depend. 2015;149:71\u20139.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"3090_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5694\/j.1326-5377.1999.tb123490.x","volume":"171","author":"KA Dolan","year":"1999","unstructured":"Dolan KA, Wodak A. HIV transmission in a prison system in an Australian State. Med J Aust. 1999;171(1):14\u20137.","journal-title":"Med J Aust"},{"issue":"2","key":"3090_CR43","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/09595239800186951","volume":"17","author":"KA Dolan","year":"1998","unstructured":"Dolan KA, Wodak AD, Hall WD. Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug Alcohol Rev. 1998;17(2):153\u20138.","journal-title":"Drug Alcohol Rev"},{"issue":"7","key":"3090_CR44","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1007\/s10461-017-1792-8","volume":"21","author":"A Rao","year":"2017","unstructured":"Rao A, Tobin K, Davey-Rothwell M, Latkin CA. Social desirability bias and prevalence of sexual HIV risk behaviors among people who use drugs in Baltimore, Maryland: implications for identifying individuals prone to underreporting sexual risk behaviors. AIDS Behav. 2017;21(7):2207\u201314.","journal-title":"AIDS Behav"},{"issue":"4","key":"3090_CR45","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1360-0443.1993.tb02058.x","volume":"88","author":"CA Latkin","year":"1993","unstructured":"Latkin CA, Vlahov D, Anthony JC. Socially desirable responding and self-reported HIV infection risk behaviors among intravenous drug users. Addiction. 1993;88(4):517\u201326.","journal-title":"Addiction"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-03090-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-020-03090-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-020-03090-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T17:23:16Z","timestamp":1616174596000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-020-03090-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["3090"],"URL":"https:\/\/doi.org\/10.1007\/s10461-020-03090-y","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]},"assertion":[{"value":"8 November 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Dr. Schwartz reports providing consultation to Verily Life Sciences. No financial disclosures were reported by the other authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}